Parker Institute for Cancer Immunotherapy
Search
Search Close

Strategic Partnerships

Strategic Partnerships

More collaboration means more breakthroughs - from idea to impact

We have an ambitious agenda. Collaborations beyond academia are critical for us to elevate our research projects and to make our bold ideas a reality. Partnerships with the right pharmaceutical companies, biotechs and nonprofits propel cutting-edge cancer research. Investments in new technologies and emerging companies speed discoveries. This new level of collaboration can change the lives of patients—and ultimately, the world.

See Our Partners

56

Industry & Nonprofit Collaborations

14

STRATEGIC INvestments

Related

Meet Our Experts

Tarak Mody, PhD
Chief Business Officer

John Connolly, PhD
Chief Scientific Officer

The PICI Advantage

PICI offers a unique combination of expertise, resources and capabilities that includes:

  • Bridging the gap between academia and industry
  • Co-funding novel ideas and research
  • Sharing valuable data and insights from our research
  • Providing access to coordinated, cutting-edge lab infrastructure
  • Developing clinical study designs and supporting patient accrual
  • Offering the option to license future PICI discoveries and IP

Partners Help Fuel Discoveries

We look to our partners to elevate every research project and clinical trial by:

  • Co-funding novel ideas and research
  • Sharing samples and data
  • Providing experimental drugs and targets
  • Offering cutting-edge tools, reagents and sequencing